Skip to main content

Eidos Therapeutics, Inc. (NASDAQ: EIDX) Investor Investigation Over Possible Wrongdoing Announced

  • Investors who purchased shares of Eidos Therapeutics, Inc. (NASDAQ: EIDX) and currently hold any of those NASDAQ: EIDX shares have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

An investigation on behalf of current long-term investors in shares of Eidos Therapeutics, Inc. (NASDAQ: EIDX) was announced over potential breaches of fiduciary duties by certain officers and directors at Eidos Therapeutics, Inc. The investigation by a law firm concerns whether certain Eidos Therapeutics directors breached their fiduciary duties and caused damage to the company and i...



You must register (for free) or login to view the entire investigation.